HUP0303004A3 - Novel alkyl phenylimino-imidazolidine derivatives, pharmaceutical compositions containing them and their use for preparation of for treating urinary incontinence - Google Patents

Novel alkyl phenylimino-imidazolidine derivatives, pharmaceutical compositions containing them and their use for preparation of for treating urinary incontinence

Info

Publication number
HUP0303004A3
HUP0303004A3 HU0303004A HUP0303004A HUP0303004A3 HU P0303004 A3 HUP0303004 A3 HU P0303004A3 HU 0303004 A HU0303004 A HU 0303004A HU P0303004 A HUP0303004 A HU P0303004A HU P0303004 A3 HUP0303004 A3 HU P0303004A3
Authority
HU
Hungary
Prior art keywords
phenylimino
preparation
pharmaceutical compositions
compositions containing
urinary incontinence
Prior art date
Application number
HU0303004A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HUP0303004A2 publication Critical patent/HUP0303004A2/hu
Publication of HUP0303004A3 publication Critical patent/HUP0303004A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0303004A 2001-02-10 2002-01-22 Novel alkyl phenylimino-imidazolidine derivatives, pharmaceutical compositions containing them and their use for preparation of for treating urinary incontinence HUP0303004A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10106214A DE10106214A1 (de) 2001-02-10 2001-02-10 Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz
PCT/EP2002/000576 WO2002064570A1 (de) 2001-02-10 2002-01-22 Neue alkyl-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz

Publications (2)

Publication Number Publication Date
HUP0303004A2 HUP0303004A2 (hu) 2003-12-29
HUP0303004A3 true HUP0303004A3 (en) 2004-07-28

Family

ID=7673601

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303004A HUP0303004A3 (en) 2001-02-10 2002-01-22 Novel alkyl phenylimino-imidazolidine derivatives, pharmaceutical compositions containing them and their use for preparation of for treating urinary incontinence

Country Status (21)

Country Link
EP (1) EP1362038A1 (hu)
JP (1) JP2004517963A (hu)
KR (1) KR20030076653A (hu)
CN (1) CN1491216A (hu)
AR (1) AR035226A1 (hu)
BG (1) BG108036A (hu)
BR (1) BR0206949A (hu)
CA (1) CA2437809A1 (hu)
CZ (1) CZ20032146A3 (hu)
DE (1) DE10106214A1 (hu)
EA (1) EA200300835A1 (hu)
EC (1) ECSP034700A (hu)
EE (1) EE200300379A (hu)
HU (1) HUP0303004A3 (hu)
IL (1) IL157297A0 (hu)
MX (1) MXPA03007127A (hu)
NO (1) NO20033368D0 (hu)
PL (1) PL362149A1 (hu)
SK (1) SK10132003A3 (hu)
WO (1) WO2002064570A1 (hu)
ZA (1) ZA200305609B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100378097C (zh) * 2003-05-09 2008-04-02 弗·哈夫曼-拉罗切有限公司 作为α-1肾上腺素能激动剂的甲基吲哚和甲基吡咯并吡啶
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202660A (en) * 1961-10-09 1965-08-24 Boehringer Sohn Ingelheim Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
HU192986B (en) * 1984-05-23 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Process for production of imidasodiline derivatives
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
FR2761061B1 (fr) * 1997-03-20 1999-04-23 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives

Also Published As

Publication number Publication date
CA2437809A1 (en) 2002-08-22
WO2002064570A1 (de) 2002-08-22
EP1362038A1 (de) 2003-11-19
SK10132003A3 (sk) 2004-02-03
AR035226A1 (es) 2004-05-05
MXPA03007127A (es) 2003-11-18
CN1491216A (zh) 2004-04-21
BG108036A (bg) 2004-12-30
NO20033368L (no) 2003-07-28
NO20033368D0 (no) 2003-07-28
EE200300379A (et) 2003-12-15
EA200300835A1 (ru) 2004-02-26
KR20030076653A (ko) 2003-09-26
DE10106214A1 (de) 2002-08-14
JP2004517963A (ja) 2004-06-17
HUP0303004A2 (hu) 2003-12-29
ECSP034700A (es) 2003-08-29
CZ20032146A3 (cs) 2003-12-17
BR0206949A (pt) 2004-02-25
IL157297A0 (en) 2004-02-19
PL362149A1 (en) 2004-10-18
ZA200305609B (en) 2004-04-29

Similar Documents

Publication Publication Date Title
HUP0303271A3 (en) Use of rapamycin for preparation of pharmaceutical composition suitable for cancer treatment
HUP0401192A3 (en) Use of photosenzitizing agent for preparation ot, of pharmaceutical composition for treating wounds
HUP0301315A3 (en) Benzothiazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HK1091840A1 (en) Methods and compositions for therapeutic use of rna interference
HUP0300565A3 (en) 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors, their use, process for their preparation and pharmaceutical compositions containing them
HUP0303128A3 (en) Novel succinate salt of o-desmethyl-venlafaxine, process for preparation thereof, its use and pharmaceutical composition containing it
HUP0402161A3 (en) Nicotin-or isonicotin benzothiazole derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0004120A3 (en) Use of cgmp-pde5 inhibitors for the preparation of pharmaceutical compositions treating neuropathy
HUP0401537A3 (en) Thiohydantoins, process for their preparation, pharmaceutical compositions containing them and use thereof for preparation of pharmaceutical compositions
HUP0402554A3 (en) Condensated heterocyclic succinimide compounds, their use, process for the preparation of some of them and pharmaceutical compositions containing the compounds
HUP0401748A3 (en) 2-amino-4,5-trisubstituted thiazolyl derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0301683A3 (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral indopeptidase, their intermediates, process for their preparation, pharmaceutical compositions containing them and their use
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HUP0303908A2 (hu) Szelektív COX-2 inhibitorok alkalmazása inkontinencia kezelésére szolgáló gyógyszerkészítmény előállítására
HUP0400548A3 (en) Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma
HUP0204563A3 (en) Process for preparation of 3,3-diarylpropylamine derivatives and their intermediates and their use for preparation of pharmaceutical compositions
HUP0303731A3 (en) Sulfonylguanidines and their use for preparation of pharmaceutical compositions
HUP0301317A3 (en) Use of neuroprotective 7-beta-hydroxysteroids for preparation of pharmaceutical compositions
HUP0300860A3 (en) Pharmaceutical compositions suitable for treatment of urinary dysfunction
AU2002233210A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
HUP0303046A3 (en) Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence and pharmaceutical compositions containing them
HUP0500103A3 (en) Tetracyclic compounds containing oxygen and/or sulfur atom, process for the preparation of some of them, their use and pharmaceutical compositions containing them
HUP0302291A3 (en) Sulfonamide derivatives, process for their preparation and their use for preparation of pharmaceutical compositions
HUP0303004A3 (en) Novel alkyl phenylimino-imidazolidine derivatives, pharmaceutical compositions containing them and their use for preparation of for treating urinary incontinence
AU2002233209A1 (en) Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence